Navigation Links
Damon Runyon Cancer Research Foundation awards breakthrough scientists
Date:12/20/2010

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named the first recipients of the Dale F. Frey Award for Breakthrough Scientists. This new award provides additional funding to scientists completing a prestigious Damon Runyon Fellowship Award who have greatly exceeded the Foundation's highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer.

Recipients of the Frey Award were selected by leaders in biomedical research based on the following criteria: exceptional productivity and significant accomplishments during the Damon Runyon Fellowship; potential of the scientist to become a leader in the field of cancer research; potential of the research to impact the prevention, diagnosis or treatment of one or more forms of cancer. They will each receive $100,000 to be used toward their research.

The Dale F. Frey Award for Breakthrough Scientists is named for the Foundation's retiring Chairman, in recognition of his 16 years of visionary leadership and role in transforming Damon Runyon into the premier charity funding today's best young cancer researchers.

Recipients of the Dale F. Frey Award:

Ken Cadwell, PhD (Damon Runyon Fellow at Washington University in Saint Louis '08-'10)

Dr. Cadwell studies the link between inflammation and diseases such as cancer and Crohn's disease. He has discovered a new phenomenon whereby intestinal disease, in mouse, is triggered by a particular genetic mutation combined with viral infection. His long-term research goal is to learn how viral infections disrupt the balance of our immune system, hopefully leading to therapeutics that target these processes and prevent cancer. Dr. Cadwell recently moved to New York City, where he is now Assistant Professor at the New York University School of Medicine.

L. Stirling Churchman, PhD (Damon Runyon Fellow at University of California, San Francisco '08-'11)

The process of transcription (how DNA is copied to RNA) is a key point at which gene expression is regulated. Dr. Churchman has developed a new technology that for the first time allows transcription to be examined at high resolution in live cells. She will use this technology to address questions about how transcription is controlled, potentially identifying new targets and pathways for cancer treatment.


'/>"/>

Contact: Yung S. Lie
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Related biology news :

1. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 18 top young scientists
2. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 11 top young scientists
3. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 13 top young investigators
4. 2009 Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
5. BIDMC scientist John Rinn, Ph.D., receives Damon-Runyon Rachleff Innovation Award
6. Key information about breast cancer risk and development is found in junk DNA
7. Scientists discover powerful biomarker panel for the early detection of breast cancer
8. Blocking the critical structure that lets cancer cells move -- their feet
9. Missing molecules hold promise of therapy for pancreatic cancer
10. Scientists identify how virus triggers cervical and mouth cancer
11. A protein called cFLIP makes tumor cells in breast cancer resistant to treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal articles ... findings are the subject of a new article on the Surviving Mesothelioma website. ... blood, lung fluid or tissue of mesothelioma patients that can help point doctors to ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of ... their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been ... Target to its list of well-respected retailers. This list includes such fine stores ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology: